Results · Apr-Jun 2026
Valiant Laboratories Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 146% to ₹115 crore from ₹46.8 crore in Apr-Jun 2025.
Operating profit grew 1119% to ₹29.3 crore, an operating margin of 25.4% (up 20.3 points from a year ago).
Net profit grew 1059% to ₹21.1 crore from ₹1.8 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +25%, net profit +1100%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 115.3 | 46.8 | +146% |
| Operating profit (EBITDA) | 29.3 | 2.4 | +1119% |
| Operating margin | 25.4% | 5.1% | +20.3 pts |
| Net profit | 21.1 | 1.8 | +1059% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.